Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.990
-0.050 (-2.45%)
At close: Sep 14, 2026, 4:00 PM EDT
1.990
0.00 (0.00%)
After-hours: Sep 14, 2026, 4:10 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $8.81 million as of September 14, 2026. Its market cap has decreased by -93.31% in one year.
Market Cap
8.81M
Enterprise Value
-1.07M
1-Year Change
-93.31%
Ranking
Category
Stock Price
$1.99
ChartMarket Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $8.81M, a decrease of -97.53%. That is a compound annual growth rate of -78.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 8.81M | -63.29% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 9.74M |
| Senti Biosciences Holdings | 9.53M |
| Ensysce Biosciences | 9.47M |
| CytoMed Therapeutics | 9.25M |
| Exicure | 9.16M |
| Xenetic Biosciences | 9.14M |
| Traws Pharma | 8.67M |
| CNS Pharmaceuticals | 8.53M |